Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-01-05 05:08:37
- Reporting Period:
- 2008-12-31
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Biosante Pharmaceuticals Inc | BPAX | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238120 | B Philip Donenberg | 111 Barclay Blvd Suite 280 Lincolnshire IL 60069 | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2008-12-31 | 3,000 | $1.00 | 40,322 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
